Search results
Nucleus RadioPharma secures Series A investment from AstraZeneca
BioPharma-Reporter· 5 days agoThe investment from AstraZeneca marks a strategic move to further expand Nucleus's capabilities in developing targeted radiotherapies and theranostics, aimed at making cancer
Theralase(R) Successfully Destroys Lung Cancer
Digital Journal· 5 days ago...Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical stage pharmaceutical company that is dedicated to the research and development of light and/or radiation activated small molecules for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to...
Sarcoma immunotherapy clinical trial reduces risk of relapse by 43%
Medical Xpress· 6 days agoFor the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare ...
Hospice (PDQ®)
National Cancer Institute· 6 days agoHealth care professionals and health care systems face many challenges when caring for patients at the end of life (EOL). While hospice is designed specifically for EOL care, patients may decline ...
What is the 'mysterious brain disease' investigated in New Brunswick? Leaked emails prompt 5,000%...
Yahoo Canada Style· 3 days agoMen visit their doctor less frequently than women. (Image via Getty Images) Halfpoint...can also...
Clinical trial leads to FDA approved treatment for peripheral artery disease
MinnPost· 7 days agoPeripheral artery disease or PAD, said Jennifer Jones-McMeans, Ph.D., divisional vice president of...
Louisiana lawmakers approve bill to allow surgical castration of child sex offenders
USA TODAY via Yahoo News· 6 days agoHow would it be enforced? The bill gives judges the option to assess the penalty against people convicted of aggravated rape, aggravated crime against nature...would have ...
'Mountain of pebbles': Experts say Iowa's high cancer rates likely result from numerous factors
telegraphherald.com· 2 days agoWhen Laura Virtue, of Dubuque, was diagnosed with a rare form of non-Hodgkin lymphoma in 2010, it...
Outcries over Plant coach Roy Harrison’s ouster reach school board
Tampa Bay Times· 6 days agoAs a Plant High junior, Kristen Chittenden’s decorated distance-running career was derailed when she...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - ORIC...
Benzinga· 3 days agoSOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of
